Arkolith/Insider Trading/EIKN/Form 4

Column Group Opportunity III, LP

10% OwnerEikon Therapeutics, Inc. (EIKN) · full profile →Form 4 · filed Feb 9, 2026
Net Buying
Open-Market Buys
$38.1M
Open-Market Sells
$0
Net Open-Market Flow
$38.1M
Transactions
17
10 non-derivative · 7 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2026Buy(P)631K$18.00$11.4M1.3M
Feb 6, 2026Conversion(C)688K——688K
Feb 6, 2026Conversion(C)4K——99K
Feb 6, 2026Buy(P)50K$18.00$892K149K
Feb 6, 2026Buy(P)1.4M$18.00$25.9M4.3M
Feb 6, 2026Conversion(C)1.3M——1.4M
Feb 6, 2026Conversion(C)1.4M——2.8M
Feb 6, 2026Conversion(C)111K——2.9M
Feb 6, 2026Conversion(C)44K——48K
Feb 6, 2026Conversion(C)48K——95K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2026Conversion(C)5.1M——0
Feb 6, 2026Conversion(C)28K——0
Feb 6, 2026Conversion(C)9.7M——0
Feb 6, 2026Conversion(C)357K——0
Feb 6, 2026Conversion(C)827K——0
Feb 6, 2026Conversion(C)330K——0
Feb 6, 2026Conversion(C)10.5M——0

Transaction Codes

P
Open-market purchase
C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-043320) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML